Tokyo, Japan

Takashi Nishigaki

This inventor holds 2 USPTO granted patents. Top assignees: Sankyo Company, Limited, Ube Industries, Inc.. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takashi Nishigaki. Retrieved from https://idiyas.com/inventor/takashi-nishigaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Takashi Nishigaki: Innovator in Pharmaceutical Chemistry

Introduction

Takashi Nishigaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

Nishigaki holds 2 patents, showcasing his innovative work. His latest patents include a trifluoromethylquinolinecarboxylic acid derivative, which relates to an 8-trifluoromethylquinolinecarboxylic acid derivative. This invention is represented by a specific formula and has potential applications in medicinal chemistry. Another notable patent involves inhibitors of HIV protease, which are compounds designed to inhibit the activity of HIV protease, thus offering potential treatment options for AIDS.

Career Highlights

Throughout his career, Nishigaki has worked with notable companies such as Sankyo Company, Limited and Ube Industries, Inc. His work in these organizations has contributed to advancements in pharmaceutical research and development.

Collaborations

Nishigaki has collaborated with esteemed colleagues, including Tomio Kimura and Tetsushi Katsube. These collaborations have further enriched his research and innovation in the field.

Conclusion

Takashi Nishigaki's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of important therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…